definiens: ( as defined in Section 101(35A ) of Bankruptcy Code ) . Each Partyhereby acknowledges that ( i ) copies of research data, ( ii ) laboratory samples, ( iii ) product samples, ( iv ) formulas, ( v)laboratory notes and notebooks, ( vi ) data and results related to clinical trials, ( vii ) Regulatory Filings and RegulatoryApprovals, ( viii ) rights of reference in respect of Regulatory Filings and Regulatory Approvals, ( ix ) pre - clinical researchdata and results, and ( x ) marketing, advertising and promotional materials, in each case, that relate to suchintellectual property, constitute of such intellectual property pursuant to Section 365(n ) of theBankruptcy Code . Each Party agrees not to interfere with the other Party ’s exercise, pursuant to Section 365(n ) of theBankruptcy Code, of rights and licenses to intellectual property licensed hereunder and embodiments thereof andagrees to use Commercially Reasonable Efforts to assist such other Party to obtain such intellectual property andembodiments thereof in the possession or control of Third Parties as reasonably necessary for such other Party toexercise, pursuant to Section 365(n ) of the Bankruptcy Code, such rights and licenses . Each Party shall take any andall action requested by the other Party to ensure that the foregoing provisions of this Section 9.6 may be fullyeffectuated under Applicable Laws, and, if requested by the other Party, each Party shall procure that any past, existing or future creditor of the other Party irrevocably waives in writing any and all rights that such creditor may haveto the intellectual property licensed hereunder and embodiments thereof